Abiopharma

Change in holdings of interested parties/officers - amendment of report

Private placement - amendment of report

The Companys outstanding liabilities as of March 31, 2026, by maturity dates

Q1 report for 2026

Events and transactions

Prospectus, shelf prospectus, shelf offering report

The company’s liability position as of 31.3.26, by maturity dates

Q1 2026 report

Events and transactions

Q1 report for 2026 - iXBRL report